Autonomic Nervous System Modulation for Parasympathetic Bias
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatment options for health conditions often focus on symptom relief rather than addressing the underlying causes, leading to a need for new protocols that target the root of the issue rather than just the symptoms.
Innovation Solution
Modulating the autonomic nervous system by increasing the sympathetic/parasympathetic activity ratio through pharmacological and electrical means to treat parasympathetic bias mediated conditions, which involves administering effective amounts of pharmacological agents or applying electrical stimulation to specific areas of the autonomic nervous system.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If current treatment options are used, then symptom relief is achieved, but the underlying cause of the condition is not addressed
Solution Approach 1:
The patent extracts and targets the underlying cause of conditions by identifying and modulating specific autonomic nervous system imbalances (parasympathetic bias) rather than treating symptoms. This is achieved through electrical stimulation devices that directly influence autonomic nervous system activity to correct the root cause.
Solution Approach 2:
The patent uses electrical stimulation as an intermediary mechanism to modulate autonomic nervous system activity. The stimulation device acts as a mediator between external control and the autonomic nervous system, enabling precise control over sympathetic and parasympathetic balance to treat underlying causes.
2Reliability
If the autonomic nervous system is modulated to increase sympathetic/parasympathetic activity ratio, then the underlying condition is treated, but treatment complexity increases
Solution Approach 1:
The patent employs a universal electrical stimulation device that can treat multiple different conditions by modulating autonomic nervous system balance. The same basic device platform addresses various conditions including IBS, asthma, allergies, and other parasympathetic bias-mediated conditions, reducing overall treatment complexity despite the sophisticated physiological mechanisms involved.
Data Source
AI summary
Methods for treating a subject for a parasympathetic bias mediated condition are provided. Aspects of the methods include modulating at least a portion of the subject's autonomic nervous system to increase the sympathetic/parasympathetic activity ratio in a manner effective to treat the subject for the parasympathetic bias mediated condition. In some instances, the subject is known to have parasympathetic bias. Also provided are devices that find use in practicing various embodiments of the methods.